Kerri Fitzgerald

DocwireNews

The total number of <a href="https://www.docwirenews.com/conference-coverage/asco-2019/screening-for-breast-cancer-reduces-mortality-is-cost-effective-in-survivors-who-received-chest-radiation-2/">cancer survivors</a> in the United States is projected to expand from 16.9 million Americans in 2019 to more than 22.1 million by 2030, according to a study published in CA: A Cancer Journal for Clinicians. This <a href="https://www.docwirenews.com/abstracts/hem-onc-abstracts/exercise-psychological-burden-childhood-cancer/">growth in survivorship</a> continues to climb despite the cancer incidence rate remaining stable in women and declining in men. This increase in survivorship is related to the growing aging population, as well as advances in early detection and treatment, according to the researchers.The American Cancer Society and the National Cancer Institute collaborate every three&nbsp;years to estimate the U.S. cancer prevalence using incidence and survival data from the Surveillance, Epidemiology, and End Results cancer registries; vital statistics from the Centers for Disease Control and Prevention&rsquo;s National Center for Health Statistics; and population projections from the U.S. Census Bureau.<blockquote class="twitter-tweet">
&gt; 22 million ppl w/ cancer hx projected to be alive by 2030. We need to know their unique CVD risks. Cancer treatment and survivorship stats, 2019 <a href="https://t.co/FU4XPcdN4z">https://t.co/FU4XPcdN4z</a> <a href="https://twitter.com/hashtag/cardioonc?src=hash&amp;ref_src=twsrc%5Etfw">#cardioonc</a> <a href="https://twitter.com/gcfmd?ref_src=twsrc%5Etfw">@gcfmd</a> <a href="https://twitter.com/boback?ref_src=twsrc%5Etfw">@boback</a> <a href="https://twitter.com/CardioOncology?ref_src=twsrc%5Etfw">@CardioOncology</a> <a href="https://twitter.com/onco_cardiology?ref_src=twsrc%5Etfw">@onco_cardiology</a> <a href="https://twitter.com/AnaBaracCardio?ref_src=twsrc%5Etfw">@AnaBaracCardio</a> <a href="https://twitter.com/PrevCardioOnc?ref_src=twsrc%5Etfw">@PrevCardioOnc</a> <a href="https://twitter.com/DLenihanICOS_MD?ref_src=twsrc%5Etfw">@DLenihanICOS_MD</a> <a href="https://t.co/7U2jNuL87A">pic.twitter.com/7U2jNuL87A</a>
&mdash; Eric H Yang, MD (@datsunian) <a href="https://twitter.com/datsunian/status/1138789998314938368?ref_src=twsrc%5Etfw">June 12, 2019</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>More than 16.9&nbsp;million Americans (8.1&nbsp;million males and 8.8&nbsp;million females) with a history of cancer were alive on January 1, 2019, with more than 22.1 million projected by January 1, 2030. The three most common cancers in 2019 are prostate (3,650,030), colon and rectum (776,120), and melanoma of the skin (684,470) in men, and breast (3,861,520), uterine corpus (807,860), and colon and rectum (768,650) in women.More than half of survivors (56%) were diagnosed within the past 10&nbsp;years, and 64% are 65&nbsp;years or older.<h2>Challenges remain for survivors</h2>The researchers highlighted some challenges that still present for this patient population, including &ldquo;a fractured healthcare system; poor integration of survivorship care between the oncology and primary care settings; clinician workforce shortages and knowledge gaps about the needs of cancer survivors; lack of strong evidence&#8208;based guidelines for post-treatment care; and financial and other barriers to quality care, particularly among the medically underserved.&rdquo;&ldquo;Although there are growing numbers of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence&#8208;based resources are needed to optimize care,&rdquo; the researchers concluded.

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Number of Cancer Survivors Projected to Top 22 Million by 2030

Oncology

The total number of cancer survivors in the United States is projected to expand from 16.9 million Americans in 2019 to more than 22.1 million by 2030

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe